A detailed history of Spc Financial, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Spc Financial, Inc. holds 5,128 shares of BMY stock, worth $295,783. This represents 0.02% of its overall portfolio holdings.

Number of Shares
5,128
Previous 5,849 12.33%
Holding current value
$295,783
Previous $242,000 9.5%
% of portfolio
0.02%
Previous 0.02%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

SELL
$39.66 - $51.75 $28,594 - $37,311
-721 Reduced 12.33%
5,128 $265,000
Q2 2024

Aug 01, 2024

SELL
$40.25 - $52.99 $53,089 - $69,893
-1,319 Reduced 18.4%
5,849 $242,000
Q1 2024

May 03, 2024

SELL
$47.98 - $54.4 $40,303 - $45,696
-840 Reduced 10.49%
7,168 $388,000
Q4 2023

Feb 05, 2024

SELL
$48.48 - $57.85 $159,402 - $190,210
-3,288 Reduced 29.11%
8,008 $410,000
Q3 2023

Nov 09, 2023

SELL
$57.89 - $64.73 $16,903 - $18,901
-292 Reduced 2.52%
11,296 $655,000
Q2 2023

Aug 03, 2023

BUY
$63.71 - $70.74 $73,457 - $81,563
1,153 Added 11.05%
11,588 $741,000
Q1 2023

May 09, 2023

BUY
$65.71 - $74.53 $7,819 - $8,869
119 Added 1.15%
10,435 $723,000
Q4 2022

Jan 31, 2023

BUY
$68.48 - $81.09 $23,831 - $28,219
348 Added 3.49%
10,316 $742,000
Q3 2022

Oct 26, 2022

BUY
$0.13 - $76.84 $65 - $38,573
502 Added 5.3%
9,968 $709,000
Q2 2022

Aug 03, 2022

SELL
$72.62 - $79.98 $1,307 - $1,439
-18 Reduced 0.19%
9,466 $729,000
Q1 2022

May 02, 2022

BUY
$61.48 - $73.72 $17,460 - $20,936
284 Added 3.09%
9,484 $693,000
Q4 2021

Jan 31, 2022

BUY
$53.63 - $62.52 $14,748 - $17,193
275 Added 3.08%
9,200 $574,000
Q3 2021

Nov 05, 2021

BUY
$59.17 - $69.31 $9,171 - $10,743
155 Added 1.77%
8,925 $528,000
Q2 2021

Jul 29, 2021

BUY
$61.91 - $67.42 $50,642 - $55,149
818 Added 10.29%
8,770 $586,000
Q1 2021

Apr 22, 2021

SELL
$59.34 - $66.74 $97,495 - $109,653
-1,643 Reduced 17.12%
7,952 $502,000
Q4 2020

Jan 29, 2021

SELL
$57.74 - $65.43 $84,877 - $96,182
-1,470 Reduced 13.29%
9,595 $595,000
Q3 2020

Oct 26, 2020

BUY
$57.43 - $63.64 $53,984 - $59,821
940 Added 9.28%
11,065 $667,000
Q2 2020

Jul 24, 2020

BUY
$54.82 - $64.09 $32,892 - $38,454
600 Added 6.3%
10,125 $595,000
Q1 2020

Apr 16, 2020

BUY
$46.4 - $67.43 $12,760 - $18,543
275 Added 2.97%
9,525 $531,000
Q4 2019

Jan 23, 2020

BUY
$49.21 - $64.19 $237,438 - $309,716
4,825 Added 109.04%
9,250 $594,000
Q3 2019

Oct 18, 2019

SELL
$42.77 - $50.71 $83,401 - $98,884
-1,950 Reduced 30.59%
4,425 $224,000
Q2 2019

Aug 01, 2019

BUY
$44.62 - $49.34 $13,386 - $14,802
300 Added 4.94%
6,375 $289,000
Q1 2019

Apr 26, 2019

BUY
$45.12 - $53.8 $274,104 - $326,835
6,075 New
6,075 $290,000
Q4 2018

Jan 25, 2019

SELL
$48.76 - $63.23 $237,705 - $308,246
-4,875 Closed
0 $0
Q3 2018

Oct 25, 2018

BUY
$55.19 - $62.25 $8,278 - $9,337
150 Added 3.17%
4,875 $303,000
Q2 2018

Jul 20, 2018

SELL
$50.53 - $62.98 $59,069 - $73,623
-1,169 Reduced 19.83%
4,725 $261,000
Q4 2017

Jan 16, 2018

BUY
$59.94 - $65.35 $89,910 - $98,024
1,500 Added 34.14%
5,894 $361,000
Q3 2017

Oct 27, 2017

BUY
$55.23 - $63.74 $242,680 - $280,073
4,394
4,394 $280,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Spc Financial, Inc. Portfolio

Follow Spc Financial, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Spc Financial, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Spc Financial, Inc. with notifications on news.